Literature DB >> 11126000

Effects of derivatives of NGP 1-01, a putative calcium channel antagonist, on electrically stimulated guinea-pig papillary muscle.

W Liebenberg1, J J Van der Walt, C J Van der Schyf.   

Abstract

In earlier work we have reported calcium antagonistic properties for the polycyclic compound NGP 1-01. We now have derivatized NGP 1-01 by side-chain substitution to obtain ten novel aromatic and aliphatic imino-keto and amino-ether compounds. Electrophysiological tests were conducted on these compounds using isolated guinea-pig papillary muscle preparations to record calcium-mediated (slow) action potentials (APs). The lipophilicities of the compounds, expressed as chromatographically determined RM values, were measured and the molecular surface areas calculated. Several derivatives showed increased activity compared with NGP 1-01. All compounds with aromatic side-chains (benzyl, phenethyl, phenylpropyl) were active (concentrations required for complete suppression of the AP varied between 1 x 10(-5) M and 5 x 10(-5) M) and compounds with shorter (methyl, butyl) aliphatic side-chains were inactive whilst activity increased dramatically in those compounds with octyl side-chains. Lipophilicity and calculated molecular volumes correlated linearly and bulkier, more lipophilic molecules had increasing activities in the electrophysiological assay. We therefore conclude that bulky substituents on the nitrogen atom increase calcium antagonistic activity in this series of compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11126000

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  2 in total

1.  NGP1-01 is a brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels.

Authors:  Cornelia Kiewert; Joachim Hartmann; James Stoll; Thomas J Thekkumkara; Cornelis J Van der Schyf; Jochen Klein
Journal:  Neurochem Res       Date:  2006-03       Impact factor: 3.996

2.  Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltage-Gated Calcium Channel Blockers.

Authors:  Lois-May Young; Werner J Geldenhuys; Olwen C Domingo; Sarel F Malan; Cornelis J Van der Schyf
Journal:  Arch Pharm (Weinheim)       Date:  2016-02-19       Impact factor: 3.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.